References
- Ashrafi, M., Hemat, M., Arabipoor, A., Yazdi, R. S., Bahman-Abadi, A., & Cheraghi, R. (2017). Predictive values of Anti-Müllerian hormone, antral follicle count and ovarian response prediction index (ORPI) for assisted reproductive technology outcomes. Journal of Obstetrics and Gynaecology, 37(1), 82–88. https://doi.org/https://doi.org/10.1080/01443615.2016.1225025
- Broer, S. L., Broekmans, F. J., Laven, J. S., & Fauser, B. C. (2014). Anti-Müllerian hormone: Ovarian reserve testing and its potential clinical implications. Human Reproduction Update, 20(5), 688–701. https://doi.org/https://doi.org/10.1093/humupd/dmu020
- Broer, S. L., van Disseldorp, J., Broeze, K. A., Dolleman, M., Opmeer, B. C., Bossuyt, P., Eijkemans, M. J. C., Mol, B.-W J., Broekmans, F. J. M., Broer, S. L., van Disseldorp, J., Broeze, K. A., Dolleman, M., Opmeer, B. C., Anderson, R. A., Ashrafi, M., Bancsi, L., Caroppo, L. E., Copperman, A., … Frank, B. (2013). Added value of ovarian reserve testing on patient characteristics in the prediction of ovarian response and ongoing pregnancy: An individual patient data approach. Human Reproduction Update, 19(1), 26–36. https://doi.org/https://doi.org/10.1093/humupd/dms041
- Broer, S. L., Dólleman, M., van Disseldorp, J., Broeze, K. A., Opmeer, B. C., Bossuyt, P. M., Eijkemans, M. J., Mol, B. W., & Broekmans, F. J, IPD-EXPORT Study Group. (2013). Prediction of an excessive response in in vitro fertilization from patient characteristics and ovarian reserve tests and comparison in subgroups: an individual patient data meta-analysis. Fertility and Sterility, 100(2), 420.e7–429.e7. https://doi.org/https://doi.org/10.1016/j.fertnstert.2013.04.024
- Delvigne, A. (2009). Epidemiology of OHSS. Reproductive BioMedicine Online, 19(1), 8–13. https://doi.org/https://doi.org/10.1016/S1472-6483(10)60040-5
- Lensen, S. F., Wilkinson, J., Leijdekkers, J. A., La Marca, A., Mol, B. W. J., Marjoribanks, J., Torrance, H., & Broekmans, F. J. (2018). Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in vitro fertilisation plus intracytoplasmic sperm injection (IVF/ICSI). The Cochrane Database of Systematic Reviews, 2(2), CD012693. https://doi.org/https://doi.org/10.1002/14651858.CD012693.pub2
- Li, H. W R., Lee, V. C. Y., Lau, E. Y. L., Yeung, W. S. B., Ho, P. C., & Ng, E. H. U. (2014). Ovarian response and cumulative live birth rate of women undergoing in-vitro fertilisation who had discordant anti-mullerian hormone and antral follicle count measurements: A retrospective study. PLOS One, 9(10), e108493. https://doi.org/https://doi.org/10.1371/journal.pone.0108493
- Li, H. W. R., Lee, V. C. Y., Lau, E. Y. L., Yeung, W. S. B., Ho, P. C., & Ng, E. H. Y. (2013). Role of baseline antral follicle count and anti-mullerian hormone in prediction of cumulative live birth in the first in vitro fertilisation cycle: A retrospective cohort analysis. PLoS One, 8(4), e61095. https://doi.org/https://doi.org/10.1371/journal.pone.0061095
- Martins, W. P., Nastri, C. O., Rienzi, L., Van Der Poel, S. Z., Gracia, C., & Racowsky, C. (2017). Blastocyst vs cleavage-stage embryo transfer: Systematic review and meta-analysis of reproductive outcomes. Ultrasound in Obstetrics & Gynecology, 49(5), 583–591. https://doi.org/https://doi.org/10.1002/uog.17327
- Ng, E. H. Y. (2009). Adverse effects of excessive ovarian response on the pregnancy rate of in vitro fertilization treatment. Gynecological Endocrinology: The Official Journal of the International Society of Gynecological Endocrinology, 25(1), 2–7. https://doi.org/https://doi.org/10.1080/09513590802296237
- Oliveira, J. B. A., Baruffi, R. L. R., Petersen, C. G., Mauri, A. L., Nascimento, A. M., Vagnini, L., Ricci, J., Cavagna, M., & Franco, J. G. (2012). A New Ovarian Response Prediction Index (ORPI): Implications for individualized controlled ovarian stimulation. Reproductive Biology and Endocrinology, 10(1), 94. https://doi.org/https://doi.org/10.1186/1477-7827-10-94
- Oliveira, J. B. A., & Franco, J. G. (2016). The ovarian response prediction index (ORPI) as a clinical internal quality control to prevent ovarian hyperstimualtion syndrome. JBRA Assisted Reproduction, 20(3), 91–92. https://doi.org/https://doi.org/10.5935/1518-0557.20160021
- van Tilborg, T. C., Oudshoorn, S. C., Eijkemans, M. J. C., Mochtar, M. H., van Golde, R. J. T., Hoek, A., Kuchenbecker, W. K. H., Fleischer, K., de Bruin, J. P., Groen, H., van Wely, M., Lambalk, C. B., Laven, J. S. E., Mol, B. W. J., Broekmans, F. J. M., Torrance, H. L., van Tilborg, T. C., Oudshoorn, S. C., Eijkemans, M. J. C., … Torrance, H. L, on behalf of the OPTIMIST study group (2017). Individualized FSH dosing based on ovarian reserve testing in women starting IVF/ICSI: a multicentre trial and cost-effectiveness analysis. Human Reproduction, 32(12), 2485–2495. https://doi.org/https://doi.org/10.1093/humrep/dex321
- Veeck, L. L. (1999). An atlas of human gametes and conceptuses (1st ed.). CRC Press.